World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02088528
Date of registration: 11/03/2014
Prospective Registration: No
Primary sponsor: Tema Christian Eye Center
Public title: The Ghana Primary Tube Versus Trabeculectomy Study GPTVT
Scientific title: The Ghana Primary Tube Versus Trabeculectomy Study
Date of first enrolment: March 2014
Target sample size: 298
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02088528
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Ghana
Contacts
Name:     Alexander Spratt, MBBCh FRCOphth
Address: 
Telephone: +233549446981
Email: mail@gptvt.com
Affiliation: 
Name:     Alexander Spratt, MBBCh FRCOphth
Address: 
Telephone:
Email:
Affiliation:  Tema Christian Eye Center
Name:     Keith Barton, MBBCh MD FRCP FRCOphth
Address: 
Telephone:
Email:
Affiliation:  Moorfields Eye Hospital NHS Foundation Trust
Name:     Donald L Budenz, MD MPH
Address: 
Telephone:
Email:
Affiliation:  University of North Carolina, Chapel Hill
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 18 to 85 years, inclusive

- Open angle glaucoma. Including primary open angle glaucoma, pseudoexfoliative and
pigmentary glaucoma

- Intraocular pressure 18 - 40 mmHg on maximal tolerated or maximal affordable medical
therapy

- Informed consent given and consent form signed.

Exclusion Criteria:

- Unwilling or unable to give consent, unwilling to accept randomisation, or unable to
return for scheduled protocol visits

- Pregnant or nursing women

- No light perception vision

- Previous incisional intraocular surgery, other than uncomplicated clear corneal
cataract surgery

- Previous ocular laser in study eye

- Iris neovascularisation or proliferative retinopathy

- Primary angle closure or primary angle closure glaucoma

- Iridocorneal endothelial syndrome or anterior segment dysgenesis

- Epithelial or fibrous downgrowth

- Aphakia

- Chronic or recurrent uveitis

- Steroid-induced glaucoma

- Severe posterior blepharitis

- Unwilling to discontinue contact lens use after surgery

- Previous cyclodestructive procedure

- Glaucoma secondary to penetrating keratoplasty, trauma, retinal disease/surgery or
neovascular disease

- Conjunctival scarring from prior ocular surgery, trauma or cicatrizing disease
precluding a superior trabeculectomy

- Need for glaucoma surgery combined with other ocular procedures (i.e. cataract
surgery, penetrating keratoplasty, or retinal surgery) or anticipated need for urgent
additional ocular surgery



Age minimum: 18 Years
Age maximum: 85 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Glaucoma
Intervention(s)
Procedure: Trabeculectomy with mitomycin-c
Device: Aurolab glaucoma drainage device
Primary Outcome(s)
Change in intraocular pressure [Time Frame: 3 months, 6 months, 1 year, 18 months, 2 years, 2½ years, 3 years, 3½ years, 4 years, 4½ years, 5 years]
Secondary Outcome(s)
Visual acuity [Time Frame: 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 18 months, 2 years, 2½ years, 3 years, 3½ years, 4 years, 4½ years, 5 years]
Quality of life [Time Frame: 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years]
Reoperation for glaucoma [Time Frame: 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 18 months, 2 years, 2½ years, 3 years, 3½ years, 4 years, 4½ years, 5 years]
Supplemental medical therapy [Time Frame: 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 18 months, 2 years, 2½ years, 3 years, 3½ years, 4 years, 4½ years, 5 years]
Complication rates [Time Frame: 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 18 months, 2 years, 2½ years, 3 years, 3½ years, 4 years, 4½ years, 5 years]
Visual field [Time Frame: 6 months, 1 year, 2 years, 3 years, 4 years, 5 years]
Secondary ID(s)
TCEC 044/13-14
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
HCA International Foundation
International Glaucoma Association
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history